• Component Description
• Eligible Sample
• Description of Laboratory Methodology
• Data Processing and Editing
• Laboratory Quality Assurance and Monitoring
• Analytic Notes
• References
• Codebook
  • SEQN - Respondent sequence number
  • LBXTC - Total Cholesterol (mg/dL)
  • LBDTCSI - Total Cholesterol( mmol/L)

National Health and Nutrition Examination Survey

2007-2008 Data Documentation, Codebook, and Frequencies

Cholesterol - Total (TCHOL_E)

Data File: TCHOL_E.xpt

First Published: September 2009

Last Revised: February 2010

Component Description

The main element of the cardiovascular disease laboratory component in NHANES is blood lipid levels. Cardiovascular disease is the leading cause of death in the United States. The data will be used to monitor the status of hyperlipidemia and the success of the National Cholesterol Education Program.

Eligible Sample

Participants aged 6 years and older were tested.

Description of Laboratory Methodology

Blood specimens were processed, stored, and shipped to University of Minnesota, Minneapolis, MN for analysis.

Detailed specimen collection and processing instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Vials are stored under appropriate frozen (–30°C) conditions until they are shipped to University of Minnesota for testing.

There were changes (from the previous 2 years of NHANES) to equipment, lab method and lab site;

During 2005-2006 Johns Hopkins University perform the lipids testing. Beginning in 2007, the University of Minnesota performed the lipids testing.

There were changes in the instruments used to measure total cholesterol. In 2005, total cholesterol was measured enzymatically in serum using the Roche Hitachi 717. In 2006, total cholesterol was measured enzymatically in serum using the Roche Hitachi 717 and 912. In 2007, total cholesterol was measured in serum using Roche Modular P chemistry analyzer. No adjustment of values was necessary to account for the change in instrumentation for total cholesterol between 2005-2006 and 2007-2008.

Roche Modular P chemistry analyzer

In this enzymatic method, esterified cholesterol is converted to cholesterol by cholesterol esterase. The resulting cholesterol is then acted upon by cholesterol oxidase to produce cholest-4-en-3-one and hydrogen peroxide. The hydrogen peroxide then reacts with 4-aminophenazone in the presence of peroxidase to produce a colored product that is measured at 505 nm (secondary wavelength = 700 nm). The final step is known as the Trinder reaction. This method is a single reagent, endpoint reaction that is specific for cholesterol.

Cholesterol, a steroid molecule with a hydroxyl group in the C3 position, is synthesized in many types of tissue, but mainly in the liver and intestinal wall. About 75 per cent of cholesterol is newly synthesized, with the remainder originating from dietary intake. Cholesterol measurement is performed to screen for atherosclerotic risk and in the diagnosis and treatment of disorders involving elevated cholesterol as well as lipid and lipoprotein metabolic disorders.

Data Processing and Editing

Read the General Documentation on Laboratory Data file for detailed data processing and editing protocols. The analytical methods are described in the Description of Laboratory Methodology section above. One calculation variable was created in this data file. The formula for their calculation is as follows:

LBDTCSI: 

The total cholesterol in mg/dL (LBXTC) was converted to mmol/L (LBDTCSI) by multiplying by 0.02586.

Laboratory Quality Assurance and Monitoring

The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Amendments mandates. Detailed QA/QC instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Read the General Documentation of Laboratory Data file for detailed QA/QC protocols.

Analytic Notes

The analysis of NHANES laboratory data must be conducted with the key survey design and basic demographic variables. The NHANES Household Questionnaire Data Files contain demographic data, health indicators, and other related information collected during household interviews. The Household Questionnaire Data Files also contain all survey design variables and sample weights required to analyze these data. The Phlebotomy Examination file includes auxiliary information on duration of fasting, the time of day of the venipuncture, and the conditions precluding venipuncture. The Household Questionnaire and Phlebotomy Exam files may be linked to the laboratory data file using the unique survey participant identifier SEQN.

In cases, where the result was below the limit of detection, the value for that variable is the detection limit divided by the square root of two.

Exam sample weights should be used for analyses. Please refer to the Analytic Guidelines for further details on the use of sample weights and other analytic issues. The Analytic Guidelines are available on the NHANES website.

References

• Package insert for C.F.A.S. Lipids, 2005.
• Roche/Hitachi Modular Analytics Operator’s Manual, version 2.0, October 2006.
• Roche/Hitachi System Application Sheet for HDL-C plus 2^nd generation, 2005.
• Roche/Hitachi System Application Sheet for HDL-C plus 3^rd generation, 2007.

Codebook and Frequencies